Literature DB >> 33704763

Infection of Immunocompetent Conventional Mice with Shiga Toxin-Producing E. coli: The DSS + STEC Model.

Gregory Hall1,2, Shinichiro Kurosawa3, D J Stearns-Kurosawa3.   

Abstract

Previous methods of infecting mice with Shiga toxin-producing E. coli (STEC) required suppression of host immune function or ablation of the gut microbiota to induce susceptibility to gastrointestinal colonization. Consequently, many pathogen-host interactions occurring in immunocompetent hosts during STEC infection and Shiga toxicosis have remained unclear. The following protocol describes the use of dextran sulfate sodium (DSS) to induce a mild colitis in immunocompetent conventional C57BL/6 mice to facilitate susceptibility to STEC infection by oral gavage. STEC colonization in infected mice was confirmed by recovery of live STEC via fecal cultures and quantified via quantitative polymerase chain reaction of fecal DNA for the STEC-specific gene eae. DSS colitis is well established, broadly reproducible, and does not require specialized equipment or high levels of technical proficiency to be a useful method of inducing susceptibility to gastrointestinal STEC colonization. The DSS + STEC mouse model provides a novel and useful tool for the exploration of local STEC-host interactions in the gut environment and the pathogenesis of Shiga toxicosis.

Entities:  

Keywords:  DSS; DSS + STEC; Dextran sulfate sodium colitis; Fecal DNA isolation; STEC; Shiga toxin-producing E. coli; Shiga toxins

Mesh:

Substances:

Year:  2021        PMID: 33704763     DOI: 10.1007/978-1-0716-1339-9_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  9 in total

Review 1.  Isolation, genotyping and antimicrobial resistance of Shiga toxin-producing Escherichia coli.

Authors:  Bianca A Amézquita-López; Marcela Soto-Beltrán; Bertram G Lee; Jaszemyn C Yambao; Beatriz Quiñones
Journal:  J Microbiol Immunol Infect       Date:  2017-07-18       Impact factor: 4.399

2.  Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.

Authors:  Shannon D Manning; Alifiya S Motiwala; A Cody Springman; Weihong Qi; David W Lacher; Lindsey M Ouellette; Janice M Mladonicky; Patricia Somsel; James T Rudrik; Stephen E Dietrich; Wei Zhang; Bala Swaminathan; David Alland; Thomas S Whittam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

3.  Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2.

Authors:  A Donohue-Rolfe; I Kondova; S Oswald; D Hutto; S Tzipori
Journal:  J Infect Dis       Date:  2000-05-09       Impact factor: 5.226

4.  Dextran Sulfate Sodium Colitis Facilitates Colonization with Shiga Toxin-Producing Escherichia coli: a Novel Murine Model for the Study of Shiga Toxicosis.

Authors:  Gregory Hall; Shinichiro Kurosawa; D J Stearns-Kurosawa
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

5.  Chemically induced mouse models of intestinal inflammation.

Authors:  Stefan Wirtz; Clemens Neufert; Benno Weigmann; Markus F Neurath
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

6.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis.

Authors:  H S Cooper; S N Murthy; R S Shah; D J Sedergran
Journal:  Lab Invest       Date:  1993-08       Impact factor: 5.662

Review 7.  Dextran sodium sulphate colitis mouse model: traps and tricks.

Authors:  Martina Perše; Anton Cerar
Journal:  J Biomed Biotechnol       Date:  2012-05-14

Review 8.  Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.

Authors:  Chad L Mayer; Caitlin S Leibowitz; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

9.  Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice.

Authors:  Yen-Lin Huang; Christophe Chassard; Martin Hausmann; Mark von Itzstein; Thierry Hennet
Journal:  Nat Commun       Date:  2015-08-25       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.